NuVasive taps Medtronic surgical innovation prez Barry as new CEO | Personnel Moves – October 19, 2018

NuVasive (NSDQ:NUVA) said today it named Medtronic (NYSE:MDT) surgical innovations prez J. Barry as its new CEO, replacing Gregory Lucier, effective November 5. Barry will also join the company’s board of directors, where Lucier will continue to serve as board chair and aid in transition efforts, the San Diego-based company said. NuVasive also said that it promoted current strategy, tech and corp dev exec VP Matt Link to president. Link has worked with NuVasive since 2006, holding numerous roles in the company primarily around building the US commercial organization. In his role with Medtronic, Barry leads the company’s second largest business with $5.5 billion in annual revenue, NuVasive said, leading more than 14,000 employees in 78 countries. Prior to joining Medtronic, Barry held commercial and leadership roles at Covidien. “On behalf of the board of directors, I want to thank Greg for his many contributions to NuVasive—first as a member of the board, and then as our chairman and CEO. Greg quickly shaped NuVasive into a global spine systems innovator, delivering highly differentiated technologies and procedurally integrated solutions to the market, improving patient outcomes by enabling better clinical decision-making and execution. We look forward to continuing to work with Greg, leveraging his business leadership and industry expertise as chairman of the board. Succession planning is one of the most important responsibilities for a board of direc...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Bigfoot Biomedical Cardinal Health Clearside Biomedical fundamentalvr IRRAS Nuvasive Personnel Moves Simplify Medical Source Type: news